Vimarsana
Biggest News Aggregation in the World

Allo 316 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allo 316. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allo 316 Today - Breaking & Trending Today

Dr Srour on the Phase 1 TRAVERSE Study of ALLO-316 in Metastatic Clear Cell RCC - Vimarsana News

Dr Srour on the Phase 1 TRAVERSE Study of ALLO-316 in Metastatic Clear Cell RCC

Published: April 18, 2023

Samer A. Srour, MB, ChB, MS, discusses the study design of the phase 1 TRAVERSE study, and key data on the use of ALLO-316 in patients with advanced or metastatic clear cell renal cell carcinoma.

Source: onclive.com
Related Topics:
United StatesSamera SrourDepartment Of Stem Cell TransplantationDivision Of Cancer MedicineUniversity Of Texas Md Anderson Cancer CenterStem Cell TransplantationCellular TherapyCancer MedicineCancer CenterB ChbThe University Of Texas Md Anderson Cancer CenterPhase 1 Traverse StudyAllo 316Dvanced Or Metastatic Clear Cell Renal Carcinoma
ALLO-316 Demonstrates Antitumor Activity in Advanced Clear Cell RCC - Vimarsana News

ALLO-316 Demonstrates Antitumor Activity in Advanced Clear Cell RCC

Published: April 17, 2023

The allogeneic anti-CD70 CAR T-cell therapy ALLO-316 elicited signals of antitumor activity and showed a tolerable safety profile in patients with advanced or metastatic clear cell renal cell carcinoma.

Source: onclive.com
Related Topics:
United StatesNoord HollandUniversity Medical CenterSamera SrourJohn HaanenNetherlands Cancer InstituteDivision Of Cancer MedicineUniversity Of Texas Md Anderson Cancer CenterLeiden University Medical CenterCentre Hospitalier Universitaire VaudoisDepartment Of Stem Cell TransplantationCancer CenterStem Cell TransplantationAllo 316Renal Cell CarcinomaGenitourinary CancerAdvanced Clear Cell RccCart Cell TherapyCd70 Targeted CarAacr Annual MeetingTraverse TrialMd Anderson Cancer CenterB Chb